ECONOMY

AstraZeneca Greece has developed and implemented a comprehensive Compliance Framework designed to strengthen ethical business practices and ensure continuous adherence to pharmaceutical industry requirements.

The framework is built around eight key pillars:

Culture & Organisation
Risk Assessment
Standards & Procedures
Training & Communications
Oversight & Monitoring
Assurance Activities
Reporting
Investigation & Remediation

A unique characteristic of AstraZeneca's Compliance operating model is the clear distinction between:

Operational Compliance, responsible for ethical culture, risk assessment, standards, procedures and employee training.

Compliance Assurance, responsible for monitoring activities, issue management, investigations and corrective actions.

A key differentiator is the Compliance Ambassadors Programme, engaging employees outside the Compliance function as advocates of ethical decision-making and responsible business behaviour.

The framework is supported by:

Annual Compliance Plans aligned with Senior Leadership priorities.
Mandatory Code of Ethics training.
New employee onboarding compliance programmes.
Specialised training for high-risk areas.
Annual Ethics Week activities.

AstraZeneca also applies structured Enterprise Risk Management processes and documented Compliance Risk Assessments for new, complex or high-risk activities.

Compliance monitoring follows the Three Lines of Defence model, ensuring shared accountability between Management, Compliance and independent auditors.

Innovation is further supported through the DITTO Digital Compliance Monitoring Tool, which uses internal data to identify potential risks, support first-line monitoring and enable proactive actions.